Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination
- 1 September 2021
- journal article
- letter
- Published by Elsevier in Journal of Infection
- Vol. 83 (3) , 381-412
Abstract
No abstract availableAll Related Versions
This publication has 8 references indexed in Scilit:
- Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workersJournal of Infection, 2021
- Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient SurveyLife, 2021
- Self-reported real-world safety and reactogenicity of COVID-19 vaccines: An international vaccine-recipient surveymedRxiv, 2021
- Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individualsThe Lancet, 2021
- SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional studyThorax, 2020
- Persistent Symptoms in Patients After Acute COVID-19JAMA, 2020
- ‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemicEuropean Journal of Epidemiology, 2020
- Assessing Response Rates and Nonresponse Bias in Web and Paper SurveysResearch in Higher Education, 2003